These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22162978)

  • 61. Established and emerging factors affecting the progression of nonalcoholic fatty liver disease.
    Kechagias S; Nasr P; Blomdahl J; Ekstedt M
    Metabolism; 2020 Oct; 111S():154183. PubMed ID: 32061907
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy.
    Zhang QQ; Lu LG
    J Clin Transl Hepatol; 2015 Mar; 3(1):78-84. PubMed ID: 26357637
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment.
    Patel AH; Peddu D; Amin S; Elsaid MI; Minacapelli CD; Chandler TM; Catalano C; Rustgi VK
    J Clin Transl Hepatol; 2023 Apr; 11(2):502-515. PubMed ID: 36643037
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia.
    Mehta A; Lee TB; Alebna P; Grandhi GR; Dixon DL; Salloum FN; Sanyal AJ; Siddiqui MS
    J Clin Lipidol; 2023; 17(6):828-833. PubMed ID: 37957050
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease.
    Nobili V; Alkhouri N; Bartuli A; Manco M; Lopez R; Alisi A; Feldstein AE
    Pediatr Res; 2010 Jun; 67(6):665-70. PubMed ID: 20496475
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship.
    Muzica CM; Sfarti C; Trifan A; Zenovia S; Cuciureanu T; Nastasa R; Huiban L; Cojocariu C; Singeap AM; Girleanu I; Chiriac S; Stanciu C
    Can J Gastroenterol Hepatol; 2020; 2020():6638306. PubMed ID: 33425804
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.
    Kosmalski M; Ziółkowska S; Czarny P; Szemraj J; Pietras T
    J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268466
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nonalcoholic Fatty Liver Disease (NAFLD) and Risk of Cardiac Arrhythmias: A New Aspect of the Liver-heart Axis.
    Mantovani A
    J Clin Transl Hepatol; 2017 Jun; 5(2):134-141. PubMed ID: 28660151
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Associations between nonalcoholic fatty liver disease and ischemic stroke.
    Alkagiet S; Papagiannis A; Tziomalos K
    World J Hepatol; 2018 Jul; 10(7):474-478. PubMed ID: 30079133
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Soejima Y; Fukusato T
    World J Gastroenterol; 2012 May; 18(19):2300-8. PubMed ID: 22654421
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.
    Kuraji R; Shiba T; Dong TS; Numabe Y; Kapila YL
    World J Gastroenterol; 2023 Feb; 29(6):967-996. PubMed ID: 36844143
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Overview of Updated Practice Guidelines for Pediatric Nonalcoholic Fatty Liver Disease.
    Shah J; Okubote T; Alkhouri N
    Gastroenterol Hepatol (N Y); 2018 Jul; 14(7):407-414. PubMed ID: 30166956
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
    Paschos P; Athyros VG; Tsimperidis A; Katsoula A; Grammatikos N; Giouleme O
    Curr Vasc Pharmacol; 2018; 16(3):269-275. PubMed ID: 28676018
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of intestinal flora in the development of nonalcoholic fatty liver disease in children.
    Zhang J; Shi M; Zhao C; Liang G; Li C; Ge X; Pei C; Kong Y; Li D; Yang W; Cao B; Fu L; Yan Y; Wu J; Zhou J; Fang Y; Meng X; Li Y; Wang L
    Microbiol Spectr; 2024 Feb; 12(2):e0100623. PubMed ID: 38189294
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease.
    Alam S; Fahim SM
    World J Hepatol; 2021 Oct; 13(10):1203-1207. PubMed ID: 34786161
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nonalcoholic fatty liver disease and cardiovascular disease.
    Liu H; Lu HY
    World J Gastroenterol; 2014 Jul; 20(26):8407-15. PubMed ID: 25024598
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers.
    Basu R; Noureddin M; Clark JM
    Mayo Clin Proc; 2022 Sep; 97(9):1700-1716. PubMed ID: 36058582
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study.
    Semmler G; Wernly S; Bachmayer S; Wernly B; Schwenoha L; Huber-Schönauer U; Stickel F; Niederseer D; Aigner E; Datz C
    Clin Transl Gastroenterol; 2021 Apr; 12(4):e00326. PubMed ID: 33821832
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.
    Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ
    Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.